Author:
El Janahi Sara,Rhalem Wajih,Boudar Zakia,Sehli Sofia,Hamdi Salsabil,Bakkali Fadil,Barrijal Said,Al Idrissi Najib,Nejjari Chakib,Ghazal Hassan
Publisher
Springer Nature Switzerland
Reference27 articles.
1. Ratjen, F., Bell, S.C., Rowe, S.M., Goss, CH., Quittner, A.L., Bush,A.: Cystic fibrosis. Nat. Rev. Dis. Primer 1, 15010 (2015). https://doi.org/10.1038/nrdp.2015.10
2. Garcia, M.A.S., Yang, N., Quinton, P.M.: Normal mouse intestinal mucus release requires cystic fibrosis transmembrane regulator–dependent bicarbonate secretion. J. Clin. Invest. 119(9), 2613–2622 (2009). https://doi.org/10.1172/JCI38662
3. Vernocchi, P., Del Chierico, F., Quagliariello, A., Ercolini, D., Lucidi, V., Putignani, L.: A metagenomic and in silico functional prediction of gut microbiota profiles may concur in discovering new cystic fibrosis patient-targeted probiotics. Nutrients 9(12), 1342 (2017). https://doi.org/10.3390/nu9121342
4. Jafari, S.-A., Mehdizadeh-Hakkak, A., Kianifar, H.-R., Hebrani, P., Ahanchian, H., Abbasnejad, E.: Effects of probiotics on quality of life in children with cystic fibrosis. Iran J. Pediatr. 23(6) (2013)
5. Lopes-Pacheco, M., Pedemonte, N., Veit, G.: Discovery of CFTR modulators for the treatment of cystic fibrosis. Expert Opin. Drug Discov. 16(8), 897–913 (2021). https://doi.org/10.1080/17460441.2021.1912732